Literature DB >> 23171870

Cohort profile: the MUg Observational Cohort.

Anna Funk1, Steve Kanters, Margaret Nansubuga, Daniel Mwehire, Amber Featherstone, Eric Druyts, Mary Odiit, Edward J Mills.   

Abstract

Mildmay Uganda (MUg), an HIV treatment centre near Kampala, the capital of Uganda, has entered into a memorandum of understanding to collaborate with Canadian researchers at the University of Ottawa to develop their research programme and develop an observational cohort database (the MUg observational cohort). The primary objectives of the MUg observational cohort are to monitor clinical care and outcomes of HIV among patients on treatment and to bring awareness to trends that are functional and dysfunctional in HIV care in Uganda. The MUg observational cohort comprises 8835 individuals who initiated combination antiretroviral therapy at MUg between January 2004 and October 2011. There are considerably more women (63.2%) than men in the cohort, and age spans from newborn to 92 years old. The low median age of 31 years (interquartile range: 18-38 years) can be explained by the 24.9% of the cohort aged <18 years. The median baseline CD4 cell count among the entire cohort is 172 cells/mm(3) (interquartile range: 73-249 cells/mm(3)). Data are routinely completed at treatment initiation, and follow-up data are collected routinely through physician visits and laboratory results. Data comprise demographic, behavioural and clinical variables. Collaborations and enquiries relating to the MUg observational cohort are encouraged, and can be addressed to Dr Edward Mills at edward.mills@uottowa.ca.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23171870     DOI: 10.1093/ije/dys170

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  5 in total

Review 1.  Retention of Adult Patients on Antiretroviral Therapy in Low- and Middle-Income Countries: Systematic Review and Meta-analysis 2008-2013.

Authors:  Matthew P Fox; Sydney Rosen
Journal:  J Acquir Immune Defic Syndr       Date:  2015-05-01       Impact factor: 3.731

Review 2.  HIV-hepatitis B virus coinfection: epidemiology, pathogenesis, and treatment.

Authors:  Kasha P Singh; Megan Crane; Jennifer Audsley; Anchalee Avihingsanon; Joe Sasadeusz; Sharon R Lewin
Journal:  AIDS       Date:  2017-09-24       Impact factor: 4.177

3.  "The Heart Desires but the Body Refuses": Sexual Scripts, Older Men's Perceptions of Sexuality, and Implications for Their Mental and Sexual Health.

Authors:  Sylivia Karen Rutagumirwa; Ajay Bailey
Journal:  Sex Roles       Date:  2017-09-09

4.  Increased mortality among HIV-positive men on antiretroviral therapy: survival differences between sexes explained by late initiation in Uganda.

Authors:  Steve Kanters; Margaret Nansubuga; Daniel Mwehire; Mary Odiit; Margaret Kasirye; William Musoke; Eric Druyts; Sanni Yaya; Anna Funk; Nathan Ford; Edward J Mills
Journal:  HIV AIDS (Auckl)       Date:  2013-05-29

5.  Hepatitis B and HIV coinfection in Northern Uganda: Is a decline in HBV prevalence on the horizon?

Authors:  Annacarla Chiesa; Emmanuel Ochola; Letizia Oreni; Paolo Vassalini; Giuliano Rizzardini; Massimo Galli
Journal:  PLoS One       Date:  2020-11-18       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.